Kolexia
Bouhier-Leporrier Karine Gastro-entérologie
Bouhier-Leporrier Karine
Gastro-entérologie
Centre François-Baclesse
Caen, France
76 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Tumeurs neuroendocrines Tumeurs du pancréas Adénocarcinome Cellules tumorales circulantes Déficit en dihydropyrimidine déshydrogénase Anaphylaxie Tumeurs des voies biliaires

Collaborateurs

Voir plus
Galais Marie-Pierre
Galais Marie-Pierre
Centre François-Baclesse, Caen, France
Di Fiore Frederic
Di Fiore Frederic
Hôpital Charles Nicolle, Rouen, France
Bignon Anne Laure
Bignon Anne Laure
Hôpital Côte de Nacre, Caen, France
Parzy Aurelie
Parzy Aurelie
Centre François-Baclesse, Caen, France

Industries

Voir plus
Ipsen
15 collaboration(s)
Dernière en 2022
Servier
11 collaboration(s)
Dernière en 2023
Advanced Accelerator Applications
7 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
BETTER2: Randomized Phase 2 Trial Of Two Chemotherapy Regimens Plus Or Minus Bevacizumab In Patients With Well Differentiated Pancreatic Neuroendocrine Tumors
Essai Clinique (Gustave-Roussy)   07 février 2024
RePERSO: Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib
Essai Clinique (CHU Rennes)   30 janvier 2024
Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: A multicentric retrospective study.
United European gastroenterology journal   07 décembre 2023
Conventional Transarterial Chemo embolization Using Streptozocin in Patients with Unresectable Neuroendocrine Liver Metastases.
Cancers   08 août 2023
Permanent stoma after sphincter preservation for rectal cancer. A situation that occurs more often than you might think.
Frontiers in oncology   26 janvier 2023
REMINET: A EUROPEAN, MULTICENTRE, PHASE II/III RANDOMISED DOUBLE-BLIND, PLACEBO CONTROLLED STUDY EVALUATING LANREOTIDE AS MAINTENANCE THERAPY IN PATIENTS WITH NON-RESECTABLE DUODENO-PANCREATIC NEUROENDOCRINE TUMOURS AFTER FIRST-LINE TREATMENT
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   21 décembre 2022
449TiP Evaluation of regorafenib treatment PERSOnalization based on therapeutic drug monitoring in patients with metastatic colorectal cancer (mCRC): RePERSO study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
COLODIAG: Evaluation of Peripheral Blood Protein Biomarkers for Colorectal Cancer Screening
Essai Clinique (CHU Rouen)   26 août 2022
Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   29 mai 2022
LuLu-DOTATATE peptide receptor radionuclide therapy-associated myeloid neoplasms: insights from the WHO pharmacovigilance database.
European journal of nuclear medicine and molecular imaging   06 mai 2022